[1]
H. H. Ahmed, W. G. Shousha, HATEM A EL-MEZAYEN, I. A. Emara, and M. E. Hassan, “CLINICAL SIGNIFICANCE OF PROCALCITONIN AND C-REACTIVE PROTEIN IN THE PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Asian J Pharm Clin Res, vol. 10, no. 9, pp. 297–306, Sep. 2017.